MARKET OVERVIEW:
The global syringes market, valued at USD 21.1 billion in 2024, is expected to grow to USD 38.7 billion by 2033, driven by a robust CAGR of 6.99% during the forecast period (2025-2033). The rising prevalence of chronic diseases, growing demand for safe vaccination practices, and an increasing preference for single-use syringes are key drivers fueling this growth. Additionally, innovations in syringe design and government initiatives to improve healthcare delivery are expected to further accelerate market expansion.
STUDY ASSUMPTION YEARS:
- BASE YEAR: 2024
- HISTORICAL YEAR: 2019-2024
- FORECAST YEAR: 2025-2033
SYRINGES MARKET KEY TAKEAWAYS:
- The syringes market is expected to reach USD 38.7 billion by 2033, growing at a CAGR of 6.99%.
- Increasing demand for single-use syringes and safety devices.
- Rising focus on infection control and safe vaccination practices.
- Strong growth in regions such as North America, driven by regulatory initiatives.
- High prevalence of chronic diseases, especially diabetes and cancer, boosts market growth.
- The shift towards home-based healthcare and biologics supports syringe demand.
- Prominent players include B. Braun Melsungen AG, Baxter International Inc., and Becton Dickinson.
MARKET GROWTH FACTORS:
- Prevalence of Chronic Diseases:
The syringes market is being boosted effectually with the increasing incidence of chronic conditions, including diabetes, cancers, and cardiovascular diseases. The usage of syringes, such as insulin syringes for diabetes, for regular medication administration is increasing. For instance, Terumo India has introduced a specialized insulin syringe designed to provide a more comfortable and less wasteful solution for patients with chronic diseases. This is because of the increasing demand for accuracy and convenience in the management of chronic diseases. It forms part of the growth health concern.
- Technological Advancements and Safety Improvements:
With a greater emphasis laid upon infection control and patient safety, a lot of innovations are happening in the design of syringes, including creation of auto-disable syringes coupled with safety features to avoid needlestick injuries. Manufacturers like Hindustan Syringes and Medical Devices (HMD) as well as Gerresheimer are coming up with new safety-oriented designs in syringes. In addition, SCHOTT Pharma in the U.S. also boasts of increasing production capacities, thus falling in the line of advancing the companies' market prominence through innovation and meeting demand.
- Regulatory Support and Demand for Safe Vaccinations:
Governments worldwide are promoting the use of safer, more efficient syringes, especially for use within immunization programs. It is this increasing demand for the use of syringes during vaccination campaigns, combined with the favorable regulations that have been established in the public sector to support these programs, which are contributing massively towards propelling the market forward. Such initiatives will be crucial in reducing infection risk that health care settings, especially in light of the rising trend of using disposable syringes, will have to contend with. Such factors have a very significant contribution as the public faces and tackles challenges of public health across the world.
MARKET SEGMENTATION:
- By Product:
- General Syringes: Typically used for a wide range of medical applications.
- Specialized Syringes: Used for specific purposes, including insulin and safety syringes.
- Others: This includes various other types of syringes used in specialized fields.
- By Material:
- Glass Syringes: Known for their strength, durability, and resistance to heat.
- Polymer Syringes: Gaining popularity due to their flexibility and lightweight nature.
- By Usage:
- Disposable Syringes: These syringes are used only once, ensuring a high level of hygiene and reducing infection risk.
- Reusable Syringes: Used multiple times, typically after thorough sterilization.
- By Distribution Channel:
- Offline: Includes traditional retail, hospitals, and medical centers.
- Online: The rising trend of e-commerce in healthcare drives online distribution.
- By End User:
- Hospitals and Clinics: Major consumers due to the high demand for syringes in medical procedures.
- Diagnostic Centers: Utilize syringes for diagnostic tests and blood sampling.
- Specialty Centers: Focused on specific treatments that require specialized syringes.
- Others: Includes any other specialized applications requiring syringes.
- Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
REGIONAL INSIGHTS:
North America leads the global syringes market since it is supported by strict regulations enforced by governments, advanced manufacturing processes, and increased demand for medical syringes across vaccination and chronic disease management. The advanced healthcare infrastructure in the region coupled with higher infection control awareness makes North America even stronger.
RECENT DEVELOPMENTS & NEWS:
The syringe market is indeed moving toward a very innovative future with the development of new technologies in safety syringes. In 2024, Hindustan Syringes launches Dispojekt, a single-use safety syringe designed to significantly reduce injuries caused by needle sticks. Gerresheimer also added a new production unit in Mexico to serve the increasing demand of North America for ready-to-fill syringes. Additionally, SCHOTT Pharma built a new facility in the U.S. for making pre-filled syringes designed specifically for mRNA medications, reflecting the growth of the field with biologics and self-administration.
KEY PLAYERS:
- B. Braun Melsungen AG
- Baxter International Inc.
- Becton Dickinson and Company
- Cardinal Health Inc.
- Gerresheimer AG
- Hindustan Syringes & Medical Devices Ltd.
- Nipro Corporation
- Pfizer Inc.
- Retractable Technologies Inc.
- Schott AG
- Smiths Group plc
- Terumo Corporation
- Thomas Scientific LLC
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Comments (0)